| ■ 영문 제목 : Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials), By Region, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MR100
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 2월
■ 페이지수 : 100
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료 기기
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,330,000 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,730,000 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,530,000 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 혈액 투석용 인공 혈관 시장 규모가 2023년부터 2030년 사이에 CAGR 5.1% 증가하여, 2030년에는 283.7 백만달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 혈액 투석용 인공 혈관 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 시장 변동/동향/범위, 원료별 (폴리에스테르, 폴리테트라 플루오로에틸렌, 폴리우레탄, 생체 재료) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동, 아프리카) 분석, 경쟁 현황 등의 내용을 수록하고 있습니다. 덧붙여 본 리포트는 W. L. Gore & Associates, Inc., C. R. Bard, Inc., Vascudyne, Inc., LeMaitre, Getinge AB, VASCULAR GENESIS, InnAVasc Medical, Inc., CryoLife, Inc., Merit Medical Systems, BIOVIC Sdn Bhd. 와 같은 기업 정보를 포함하고 있습니다.
・조사 방법 및 범위
・개요
・시장 변동/동향/범위
・세계의 혈액 투석용 인공 혈관 시장 규모 : 원료별
- 폴리에스터제 혈액 투석용 인공 혈관의 시장 규모
- 폴리테트라 플루오로에틸렌제 혈액 투석용 인공 혈관의 시장 규모
- 폴리우레탄제 혈액 투석용 인공 혈관의 시장 규모
- 생체 재료제 혈액 투석용 인공 혈관의 시장 규모
・세계의 혈액 투석용 인공 혈관 시장 규모 : 지역별
- 북미의 혈액 투석용 인공 혈관 시장 규모
- 유럽의 혈액 투석용 인공 혈관 시장 규모
- 아시아 태평양의 혈액 투석용 인공 혈관 시장 규모
- 중남미의 혈액 투석용 인공 혈관 시장 규모
- 중동 및 아프리카의 혈액 투석용 인공 혈관 시장 규모
・경쟁 현황 |
■ 보고서 개요Hemodialysis Vascular Grafts Market Growth & Trends
The global hemodialysis vascular grafts market size is expected to reach USD 283.7 million by 2030, registering a CAGR of 5.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Vascular graft is a connection between a vein and an artery that utilizes a hollow, synthetic tube which is used to remove or return blood during hemodialysis.
Growing healthcare expenditure, advancements in technology, and increasing access to healthcare services in developing countries are the factors contributing to market growth. Advances in the design and materials used in hemodialysis vascular grafts are leading to better patient outcomes & increased demand for these products. In addition, government initiatives to improve access to healthcare and raise awareness about kidney disease & its treatment options are also contributing to the growth of the market.
Governments and private organizations are also investing more in the treatment of chronic diseases such as CKD and ESRD due to the increase in healthcare expenditure. This increased investment has led to the development of more advanced and effective hemodialysis vascular grafts, which has increased their adoption and growth in the market. In addition, as healthcare systems around the world move towards more advanced and specialized care, the demand for grafts is likely to increase, further driving market growth.
Governments around the world have recognized the growing burden of kidney disease and have begun to invest more in the treatment of this condition. For instance, the U.S. government has invested significant funds in the National Kidney Disease Education Program (NKDEP) to improve the diagnosis, treatment, and management of kidney diseases. This is expected to impel the market growth during the forecast period.
Further, the COVID-19 outbreak had a long-term growth potential as it accelerated the adoption of telemedicine and virtual consultations for kidney disease treatment, which may lead to an increase in the number of patients who can access hemodialysis treatment remotely, thus increasing the demand for hemodialysis vascular grafts.
Hemodialysis Vascular Grafts Market Report Highlights
• In 2022, the Polytetrafluoroethylene (PTFE) segment held a majority share of the market owing to the increasing incidence of End-stage Renal Disease (ESRD), the aging population as well as growing awareness about the advantages of PTFE over other materials
• The segment is anticipated to grow at the fastest rate during the forecast period owing to rising funding and investments for kidney diseases, and growing private sector investments in dialysis infrastructure
• North America held the largest share in 2022 owing to the factors such as higher healthcare spending as a portion of GDP, a rise in preference for biological & tissue-engineered grafts, and a growing number of patients with CKD
• The presence of well-defined regulatory guidelines and the increase in the adoption of biological grafts are some of the factors driving the market in North America
■ 보고서 목차Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. Country Market: Cagr Calculation
1.7. Country-Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Hemodialysis Vascular Grafts Market Snapshot
2.6. Hemodialysis Vascular Grafts Market Segment Snapshot
2.7. Hemodialysis Vascular Grafts Market Competitive Landscape Snapshot
Chapter 3. Hemodialysis Vascular Grafts Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge
3.3. Asia Pacific Nutritional Supplements Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID-19 on Hemodialysis Vascular Grafts Market
Chapter 4. Hemodialysis Vascular Grafts Market: Raw Material Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hemodialysis Vascular Grafts Market: Raw Material Movement Analysis, USD Million, 2022 & 2030
4.3. Polyester
4.3.1. Polyester Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
4.4. Polytetrafluoroethylene
4.4.1. Polytetrafluoroethylene Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
4.5. Polyurethane
4.5.1. Polyurethane Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
4.6. Biological Materials
4.6.1. Biological Materials Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
4.6.1.1. Human Saphenous & Umbilical Veins
4.6.1.1.1. Human Saphenous & Umbilical Veins Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
4.6.1.2. Tissue Engineered Materials
4.6.1.2.1. Tissue Engineered Materials Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 5. Hemodialysis Vascular Grafts Market: Regional Estimates & Trend Analysis
5.1. Hemodialysis Vascular Grafts Market Share, By Region, 2022 & 2030, USD Million
5.2. North America
5.2.1. North America hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3. Europe
5.3.1. Europe hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3.2. U.K.
5.3.2.1. U.K. hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3.4. France
5.3.4.1. France hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3.8. Norway
5.3.8.1. Norway hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.3.9. Sweden
5.3.9.1. Sweden hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.4.2. China
5.4.2.1. China hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.4.3. Japan
5.4.3.1. Japan hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.4.4. India
5.4.4.1. India hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.4.5. Thailand
5.4.5.1. Thailand hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. South Korea hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.4.7. Australia
5.4.7.1. Australia hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.5.3. Mexico
5.5.3.1. Mexico hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.5.4. Argentina
5.5.4.1. Argentina hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. South Africa hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.6.4. UAE
5.6.4.1. UAE hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Kuwait hemodialysis vascular grafts market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Overview
6.2. Financial Analysis
6.3. Product Benchmarking
6.4. Strategy Mapping
6.4.1. Product Launch
6.4.2. Acquisition
6.4.3. Collaboration
6.5. Recent Developments & Impact Analysis, by Key Market Participants
6.6. Company/Competition Categorization
6.7. List of key emerging companies/technology disruptors/innovators
6.8. Company Market Position Analysis
6.9. Company Market Share Analysis
6.10 Company Profiles
6.10.1 W. L. Gore & Associates, Inc.
6.10.2 C. R. Bard, Inc.
6.10.3 Vascudyne, Inc.
6.10.4 LeMaitre
6.10.5 Getinge AB
6.10.6 VASCULAR GENESIS
6.10.7 InnAVasc Medical, Inc.
6.10.8 CryoLife, Inc.
6.10.9 Merit Medical Systems
6.10.10 BIOVIC Sdn Bhd.
|
| ※본 조사보고서 [세계의 혈액 투석용 인공 혈관 시장 (2023~2030) : 폴리에스테르, 폴리테트라 플루오로에틸렌, 폴리우레탄, 생체 재료] (코드 : GRV23MR100) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 혈액 투석용 인공 혈관 시장 (2023~2030) : 폴리에스테르, 폴리테트라 플루오로에틸렌, 폴리우레탄, 생체 재료] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요! 세계의 혈액 투석용 인공 혈관 시장 (2023~2030) : 폴리에스테르, 폴리테트라 플루…
